The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

The shots rely on the same mRNA technology that was used to create COVID-19 vaccines. In recent weeks, scientists led by a ...